phase 2
-
Neuro
Remedy Pharmaceuticals Initiates Phase 2A Study of CIRARA™ in Spinal Cord Injury
NEW YORK–(BUSINESS WIRE)–Remedy Pharmaceuticals, a company focused on the development and commercialization of CIRARA™, a breakthrough drug for treating acute…
Read More » -
Extremities
OrthoTrophix Completed Subject Enrollment of the Phase 2 Clinical Trial of a New Cartilage Repair Therapeutic for Knee Osteoarthritis
OAKLAND, Calif., May 21, 2015 /PRNewswire/ — OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company completed subject…
Read More » -
Recon
TissueGene, Inc. Presents Phase 2 Data for Its Novel Cell Therapy for the Treatment of Osteoarthritis of the Knee
ROCKVILLE, Md., May 11, 2015 /PRNewswire/ — TissueGene Inc. is pleased to announce that Dr. Moon Jong Noh, VP of Research…
Read More »